马拉巴酮C的大鼠肝微粒体生物转化及其体外对人胃癌细胞株的细胞毒活性研究

doi:10.5246/jcps.2014.04.033

中国药学(英文版) ›› 2014, Vol. 23 ›› Issue (4): 241-245.DOI: 10.5246/jcps.2014.04.033

马拉巴酮C的大鼠肝微粒体生物转化及其体外对人胃癌细胞株的细胞毒活性研究

吴妮, 徐嵬, 张友波, 杨秀伟^*

北京大学医学部天然药物及仿生药物国家重点实验室; 药学院天然药物学系, 北京 100191

收稿日期:2013-12-19 修回日期:2014-01-26 出版日期:2014-04-28 发布日期:2014-02-13
通讯作者: *Corresponding author. Tel.: 86-10-82801569; E-mail: xwyang@bjmu.edu.cn
作者简介:*Corresponding author. Tel.: 86-10-82801569; E-mail: xwyang@bjmu.edu.cn
基金资助:
National Natural Science Foundation of China (Grant No. 30973863; 81161120429) and National Key Technology R & D Program of China (Grant No. 2011BAI07B08).

Biotransformation of malabaricone C by rat hepatic microsomes and cytotoxic activities against gastric cancer cells in vitro

Ni Wu, Wei Xu, Youbo Zhang, Xiuwei Yang^*

State Key Laboratory of Natural and Biomimetic Drugs; Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China

Received:2013-12-19 Revised:2014-01-26 Online:2014-04-28 Published:2014-02-13
Contact: *Corresponding author. Tel.: 86-10-82801569; E-mail: xwyang@bjmu.edu.cn
About author:*Corresponding author. Tel.: 86-10-82801569; E-mail: xwyang@bjmu.edu.cn
Supported by:
National Natural Science Foundation of China (Grant No. 30973863; 81161120429) and National Key Technology R & D Program of China (Grant No. 2011BAI07B08).

摘要/Abstract

摘要：

马拉巴酮C是从中药肉豆蔻 (Myristica fragrans Houtt. 的种子)中提取到的，肉豆蔻科植物所特有的一类二芳基壬烷类化合物。本文首次利用大鼠肝微粒体对其进行了生物转化研究, 明确其主要生物转化产物为马拉巴酮B。在体外对人胃癌细胞株NCI-N87和MGC803细胞毒活性评价试验中发现, 原型化合物马拉巴酮C及其生物转化产物马拉巴酮B均具有与阳性药长春瑞滨相当的细胞毒活性。两者的半数抑制浓度, 对NCI-N87细胞株分别为(42.62±3.10)和(19.80±1.70) μg/mL;对MGC803细胞株分别为(22.94±1.33)和(19.60±2.21) μg/mL。统计学分析表明, 转化产物马拉巴酮B的细胞毒活性显著性强于原型化合物马拉巴酮C (对NCI-N87细胞P<0.01, 对MGC803细胞P<0.05), 提示肝微粒体对马拉巴酮C有活化作用。马拉巴酮C在肝微粒体的生物转化途径较为单一; 马拉巴酮B和C具有治疗胃癌的开发潜力。

关键词: 马拉巴酮C? 马拉巴酮B? 肉豆蔻, 生物转化? 肝微粒体, 人胃癌细胞株NCI-N87, 人胃癌细胞株MGC803

Abstract:

Malabaricone C (1), isolated from the seeds of Myristica fragrans Houtt., belongs to a kind of diarylnonanoid compounds that are only found in Myristicaceae till now. In this study, biotransformation of 1 was investigated using rat hepatic microsomes for the first time and the main biotransformation product waselucidated as malabaricone B (2) according to the spectroscopic data. Further evaluation on human gastric cancer cell lines showed that the cytotoxic effects of malabaricone C and its metabolite malabaricone B were comparable to those of vinorelbine, with the values of IC₅₀ of (42.62±3.10) and (19.80±1.70) μg/mL on NCI-N87, and (22.94±1.33) and (19.60±2.21) μg/mL on MGC803, respectively. Statistical analysis revealed that malabaricone B had significantly stronger cytotoxicity than the parent compound(P<0.01 on NCI-N87 and P<0.05 on MGC803), which may indicate a bioactivation of malabaricone C by hepatic microsomes. These results suggest that malabaricone C has a simple biotransformation pathway by hepatic microsomes and provide valuable information for further investigation on both the parent compound and its biotransformation product as anti-gastric cancer agents or lead compounds.

Key words: Malabaricone C, Malabaricone B, Myristica fragrans, Biotransformation, Rat hepatic microsomes, Human gastric cancer NCI-N87, Human gastric cancer MGC803

中图分类号:

R284

Supporting: National Natural Science Foundation of China (Grant No. 30973863; 81161120429) and National Key Technology R & D Program of China (Grant No. 2011BAI07B08).

吴妮, 徐嵬, 张友波, 杨秀伟. 马拉巴酮C的大鼠肝微粒体生物转化及其体外对人胃癌细胞株的细胞毒活性研究[J]. 中国药学(英文版), 2014, 23(4): 241-245.

Ni Wu, Wei Xu, Youbo Zhang, Xiuwei Yang. Biotransformation of malabaricone C by rat hepatic microsomes and cytotoxic activities against gastric cancer cells in vitro[J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(4): 241-245.

参考文献

[1] Jin, D.Q.; Lim, C.S.; Hwang, J.K.; Ha, I.; Han, J.S. Biochem. Biophys. Res. Commun. 2005, 331, 1264–1269.

[2] Yang, S.; Kyun, N.M.; Jang, J.P.; Kim, K.A.; Kim, B.Y.; Sung, N.J.; Oh, W.K.; Ahn, J.S. Phytother. Res. 2006, 20, 680–682.

[3] Morita, T.; Jinno, K.; Kawagishi, H.; Arimoto, Y.; Suganuma, H.; Inakuma, T.; Sugiyama, K. J. Agric. Food Chem. 2003, 51, 1560–1565.

[4] Mukherjee, P.K.; Kumar, V.; Houghton, P.J. Phytother. Res. 2007, 21, 1142–1145.

[5] Kozhiparambil, K.P.; Ayyappath, S.; Joseph, D.C. J. Chem. Soc. 1977, 5, 587–588.

[6] Patro, B.S.; Bauri, A.K.; Mishra, S.; Chattopadhyay, S. J. Agric. Food Chem. 2005, 53, 6912–6918.

[7] Hou, J.P.; Wu, H.; Wang, Y.; Weng, X.C. Czech J. Food Sci. 2012, 30, 164–170.

[8] Kang, J.; Tae, N.; Min, B.S.; Choe, J.; Lee, J.H. Int. Immunopharmacol. 2012, 14, 302–310.

[9] Maity, B.; Yadav, S.K.; Patro, B.S.; Tyagi, M.; Band-yopadhyay, S.K.; Chattopadhyay, S. Free Radical. Biol. Med. 2012, 52, 1680–1691.

[10] Shinohara, C.; Mori, S.; Ando, T.; Tsuji, T. Biosci. Biotechnol. Biochem. 1999, 63, 1475–1477.

[11] Banerjee, D.; Bauri, A.K.; Guha, R.K.; Bandyopadhyay, S.K.; Chattopadhyay, S. Eur. J. Pharmacol. 2008, 578, 300–312.

[12] Patro, B.S.; Tyagi, M.; Saha, J.; Chattopadhyay, S. Bioorg. Med. Chem. 2010, 18, 7043–7045.

[13] Maia, A.; Schmitz-Afonso, I.; Martin, M.T.; Awang, K.; Laprevote, O.; Gueritte, F.; Litaudon, M. Planta Med. 2008, 74, 1457–1462.

[14] Hosoi, S.; Kiuchi, F.; Nakamura, N.; Imasho, M.; Ali, M.; Sasaki, Y. Chem. Pharm. Bull. 1999, 47, 37–43.

[15] Vincenza, C.; Domenico, S.; Gianfranco, L.; Sabino, R.; Giuseppe, I.; Franco, D. Int. J. Oncol. 2013, 42, 5.

[16] Kim, S.H.; Lee, D.H.; Kwon, S.H.; Lim, B.H.; Lee, S.H.; Min, B.C. Korean J. Pharmacogn. 2007, 38, 19–21.

[17] Birija, S.P.; Mrityunjay, T.; Jayati, S.; Subrata, C. Biol. Med. Chem. 2010, 18, 7043–7051.

[18] To, D.C.; Chae, J.L.; Tran, T.T; Yoon, H.B.; Nguyen, V.T.; Nguyen, T.T.; Tran, M.H.; Mi, H.W.; Jae, S.C.; Byung, S.M. Nat. Prod. Sci. 2012, 18, 97–101.

[19] Li, F.; Yang, X.W. Phytochemistry. 2008, 69, 765–771.

[20] Mosmann, T. J. Immunol. Methods. 1983, 65, 55–63.

[21] Lai, P.; Julia, Y.C.; Byunggil, Y.; Sumedha, S.G.; Hong, L. Drug Metab. Dispos. 2013, 41, 2175–2186.

[22] Guengerich, F.P. Chem. Res. Toxicol. 2001, 14, 611–650.

[23] Heider, J.; Fuchs, G. Eur. J. Biochem. 1997, 243, 577–596.

[24] Zi, J.C.; Valiente, J.; Zeng, J.; Zhan, J.X. J. Biosci. Bioeng. 2011, 112, 360–362.

[25] Maity, B.; Banerjee, D.; Bandyopadhyay, S.K.; Chatto-padhyay, S. Int. Immunopharmacol. 2009, 9, 491–498.

[26] Choi, N.H.; Choi, G.J.; Jang, K.S.; Choi, Y.H.; Lee, S.O.; Choi, J.E.; Kim, J.C. Plant Pathol. J. 2008, 24, 317–321.

[27] Banerjee, D.; Maity, B.; Bandivdeker, A.H.; Bandyo-padhyay, S.K.; Chattopadhyay, S. Pharm. Res. 2008, 25, 1601–1609.

马拉巴酮C的大鼠肝微粒体生物转化及其体外对人胃癌细胞株的细胞毒活性研究

Biotransformation of malabaricone C by rat hepatic microsomes and cytotoxic activities against gastric cancer cells in vitro

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	石金徽, 李睿悦, 杨思雨, 张红梅. 川芎的植物化学、生物活性及质量评价研究综述[J]. 中国药学(英文版), 2020, 29(11): 755-779.
[2]	王亚文, 段晓峰, 程晓晓, 张邈鑫, 李丽, 赵丁. 桑叶及其提取物对肠道功能的调节作用[J]. 中国药学(英文版), 2020, 29(11): 780-792.
[3]	徐露露, 尚展鹏, 柴跃, 张扬, 余蓉, 叶敏, 乔雪. 正向×反相离线二维液相色谱-轨道质谱联用检测通脉颗粒中的微量成分[J]. 中国药学(英文版), 2020, 29(11): 793-803.
[4]	徐方方, 孙彪, 张晓琦, 刘博. 北枳椇子中的黄酮碳苷类成分[J]. 中国药学(英文版), 2020, 29(11): 813-818.
[5]	Eric Wei Chiang Chan, Oi Yoon Michelle Soo, Yong Hui Tan, Siu Kuin Wong, Hung Tuck Chan. Nobiletin and tangeretin (citrus polymethoxyflavones): an overview on their chemistry, pharmacology and cytotoxic activities against breast cancer[J]. 中国药学(英文版), 2020, 29(7): 443-454.
[6]	王慧楠, 张景珍, 崔曰新, 王思雨, 高慧, 张瑶, 王新杰, 杨子烨, 陈梦雨, 王佩华, 张桂梅, 王英姿, 张超. 千金子制霜前后UPLC-Q-TOF/MS化学成分分析研究[J]. 中国药学(英文版), 2020, 29(7): 470-479.
[7]	徐云玲, 王昱霁, 江石平, 蔡婷婷, 王楠楠, 刘霞, 朱婉萍. 北五味子化学成分的研究[J]. 中国药学(英文版), 2020, 29(7): 480-486.
[8]	陈静, 程丽, 王富乾, 汪选斌, 张勇慧, 郝新才. 王瓜化学成分研究[J]. 中国药学(英文版), 2020, 29(6): 431-438.
[9]	范靖然, 董泽源, 匡易, 周艳霞, 乔雪, 叶敏. 乌拉尔甘草地上部分的化学成分及其PTP1B与α-葡萄糖苷酶抑制活性研究[J]. 中国药学(英文版), 2020, 29(5): 305-313.
[10]	吴翠, 徐靓, 徐博, 李卓俊, 巢志茂. 生地黄和熟地黄中5-羟甲基糠醛的含量与色泽的相关性研究[J]. 中国药学(英文版), 2020, 29(5): 314-321.
[11]	Makhmur Ahmad, Mohammad Rashid, Babar Ali, Shamshir Khan, Naseem Akhtar, Mohd Faiyaz Khan, Bibhu Prasad Panda. Immobilization of β-glucuronidase: biocatalysis of glycyrrhizin to 18β-glycyrrhetinic acid and in-silico lead finding[J]. 中国药学(英文版), 2020, 29(5): 333-340.
[12]	黄晋, 杨玲馨, 杨宁, 袁博文, 张浩, 王梦月. 荨麻抑制前列腺增生药理作用研究[J]. 中国药学(英文版), 2020, 29(4): 236-243.
[13]	刘继梅, 陈明华, 陈日道, 解可波, 陈大伟, 司书毅, 戴均贵. 内生真菌Periconia sp. F-31中的三个新化合物[J]. 中国药学(英文版), 2020, 29(4): 244-251.
[14]	杨红帅, 刘秋怡, 殷卫东, 解满江, 吉翔, 邵双宇, 梁鸿, 屠鹏飞, 张庆英. 酸枣仁和滇枣仁的HPLC指纹图谱分析及鉴别[J]. 中国药学(英文版), 2020, 29(4): 252-259.
[15]	梁晓霞, 熊城, 高迎迎, 范巧佳. 天麻内生真菌提取物抗氧化活性及天麻素的测定[J]. 中国药学(英文版), 2020, 29(3): 206-213.